Estrogen Therapy – Indications, Contraindications

Advertisements
Advertisements
Advertisements

Estrogen Therapy/Estrogen Therapy (ET)is a form of hormone replacement therapy (HRT), that are a useful in case of deficiency of estrogen therapy that indicates uncomfortable symptoms accompany menopause-related disease conditions.[rx] The Women’s Health Initiative trial has made the use of Read More …>>

Lipegfilgrastim – Uses, Dosage, Side Effects, Interaction

Lipegfilgrastim is a long-acting glycol-pegylated recombinant form of human granulocyte colony-stimulating factor (G-CSF), with hematopoietic activity. Similar to G-CSF, pegfilgrastim binds to and activates specific cell surface receptors, and stimulates neutrophil progenitor proliferation and differentiation. Therefore, this agent may prevent Read More …>>

Dosage of Filgrastim – Side Effects, Interaction

Dosage of Filgrastim/Filgrastim is a recombinant, non-pegylated human granulocyte colony-stimulating factor (G-CSF) analog. It is marketed as the brand name Neupogen by Amgen (initially approved in 1998) and as Nivestym, a biosimilar agent by Pfizer. Nivestym was approved by the FDA on Read More …>>

Filgrastim Contraindications and Side Effects

Filgrastim Contraindications and Side Effects/Filgrastim is a recombinant, non-pegylated human granulocyte colony-stimulating factor (G-CSF) analog. It is marketed as the brand name Neupogen by Amgen (initially approved in 1998) and as Nivestym, a biosimilar agent by Pfizer. Nivestym was approved by the Read More …>>

Indications and Uses of Filgrastim

Indications and Uses of Filgrastim /Filgrastim is a recombinant, non-pegylated human granulocyte colony-stimulating factor (G-CSF) analog. It is marketed as the brand name Neupogen by Amgen (initially approved in 1998) and as Nivestym, a biosimilar agent by Pfizer. Nivestym was approved by Read More …>>